Skip to main content
logo
China Resources Medical Holdings Company Limited (HKG:1515)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.555
-0.015 (-0.58%)
Aug 12, 2026, 4:08 PM HKT

HKG:1515 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
495.94565.88257.68265.86417.92
Depreciation & Amortization
584.93618.9610.86486.41182.88
Loss (Gain) From Sale of Assets
-2.0611.192.39-5.41-
Asset Writedown & Restructuring Costs
0.0332.15351.81108.8311.15
Loss (Gain) From Sale of Investments
18.1722.15145.8722.18371.56
Loss (Gain) on Equity Investments
-78.34-98.6-90.78-88.07-83.55
Stock-Based Compensation
---2.1610.11
Other Operating Activities
147.8396.98230.61159.42-348.79
Change in Accounts Receivable
142.31118.03-111.25109.17131.47
Change in Inventory
39.48-0.0765.18-17.340.21
Change in Accounts Payable
-34.06-35.249.71-152.76-31.99
Change in Unearned Revenue
4.452.2317.218.54-0.09
Change in Other Net Operating Assets
39.86-63.34-294.17-35.449.56
Operating Cash Flow
1,3591,2701,195863.59710.43
Operating Cash Flow Growth
6.95%6.29%38.39%21.56%10.37%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-514.13-563.69-486.68-466.28-198.43
Sale of Property, Plant & Equipment
18.180.0954.986.132.1
Cash Acquisitions
---3,768173.92-669.61
Divestitures
---0.01-
Investment in Securities
--872.18381.34-1,096
Other Investing Activities
169.7518.88705.46-589.1326.26
Investing Cash Flow
-326.2-544.73-2,622-494.02-1,936

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
500----
Long-Term Debt Issued
1,5501,7245,5548,6146,073
Total Debt Issued
2,0501,7245,5548,6146,073
Short-Term Debt Repaid
-500---0.26-1.56
Long-Term Debt Repaid
-2,402-2,489-5,819-8,650-5,106
Total Debt Repaid
-2,902-2,489-5,819-8,651-5,107
Net Debt Issued (Repaid)
-852.45-764.34-265.28-36.68965.15
Issuance of Common Stock
----0.54
Common Dividends Paid
-166.89-139.13-42.35-129.6-91.08
Other Financing Activities
-50.79-81.32-129.45-57.41-28.66
Financing Cash Flow
-1,070-984.8-437.08-223.69845.96

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.080.50.142.732.34
Net Cash Flow
-37.71-258.76-1,864148.61-377.32

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
844.41706.57708.44397.31512
Free Cash Flow Growth
19.51%-0.26%78.31%-22.40%17.93%
Free Cash Flow Margin
9.20%7.17%7.01%5.03%11.51%
Free Cash Flow Per Share
0.670.560.560.320.41
Levered Free Cash Flow
640.17279.571,843235.59569.68
Unlevered Free Cash Flow
660.14317.71,915270.53579.83

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
38.6663.7116.2756.419.77
Cash Income Tax Paid
132.16235.69163.4143.84135.99
Change in Working Capital
192.0421.62-313.31-87.79149.17